RNAポリメラーゼ"スイッチ領域"は,阻害剤の標的である
Jayanta Mukhopadhyay1, Kalyan Das, Sajida Ismail
1Howard Hughes Medical Institute, Rutgers University, Piscataway, NJ 08854, USA.
Cell
|October 30, 2008
まとめ
ミキソピロニン抗生物質は,スイッチ領域を標的とし,DNA結合を防ぐことで,細菌のRNAポリメラーゼ (RNAP) を阻害する. このメカニズムは,広範囲の抗菌薬の開発に新たな道を開く.
科学分野:
- 微生物学 微生物学とは
- 分子生物学は分子生物学である.
- ドラッグ・ディスカバリー・ドリッグ・ディスカバリー・ドリッグ・ディスカバリー・ドリッグ・ディスカバリー
背景:
- 細菌のRNAポリメラーゼ (RNAP) は,抗生物質の重要な標的である.
- 既存のRNAP阻害剤は,スイッチ領域とは異なるサイトを標的とする.
研究 の 目的:
- バクテリアのRNAPに作用するミクソピロニン (Myx) の作用メカニズムを解明する.
- 新しい抗生物質の標的としてRNAPスイッチ領域の可能性を調査する.
主な方法:
- 遺伝子分析 遺伝子分析
- バイオケミカルアッセイ
- 構造研究 (例えば,X線結晶学)
- 抗生物質耐性プロファイリング
主要な成果:
- MyxはRNAPのスイッチ領域に結合し,RNAP-プロモーターDNAの相互作用を抑制する.
- Myxは,転写開始に必要なRNAPアクティブセンターの開口を防ぐ.
- 構造的に関連した抗生物質 (コロロピロニン) と無関係な抗生物質 (リポスタチン) は,この抑制メカニズムを共有しています.
- Myx,corallopyronin,およびリポスタチンは,既存のRNAP阻害剤との交叉抵抗を示さない.
結論:
- RNAPスイッチ領域は,抗菌剤の新たな標的である.
- ミクソピロニンおよび関連化合物は,RNAP阻害剤の新しいクラスを表しています.
- スイッチ・リージョンをターゲットにすると,新たな作用機構を持つ広範囲の抗生物質の開発の可能性が生まれます.
関連する概念動画
The Resting Membrane Potential
117.8K
Overview
117.8K
Riboswitches
8.0K
Riboswitches are non-coding mRNA domains that regulate the transcription and translation of downstream genes without the help of proteins. Riboswitches bind directly to a metabolite and can form unique stem-loop or hairpin structures in response to the amount of the metabolite present. They have two distinct regions – a metabolite-binding aptamer and an expression platform.
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
8.0K
Resting Membrane Potential
18.4K
The relative difference in electrical charge, or voltage, between the inside and the outside of a cell membrane, is called the membrane potential. It is generated by differences in permeability of the membrane to various ions and the concentrations of these ions across the membrane.
The Inside of a Neuron is More Negative
The membrane potential of a cell can be measured by inserting a microelectrode into a cell and comparing the charge to a reference electrode in the extracellular fluid. The...
The Inside of a Neuron is More Negative
The membrane potential of a cell can be measured by inserting a microelectrode into a cell and comparing the charge to a reference electrode in the extracellular fluid. The...
18.4K
Drug-Receptor Interaction: Antagonist
4.9K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
4.9K
Neuromuscular Junction And Blockade
5.9K
The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
5.9K
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
3.6K
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
3.6K


